HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imiquimod as neoadjuvant treatment for giant keratoacanthoma arising on a background of lupus vulgaris.

AuthorsM Tsikeloudi, A Lallas, T Sidiropoulos, V Chasioti, I Lefaki, Z Apalla
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 39 Issue 1 Pg. 60-2 (Jan 2014) ISSN: 1365-2230 [Electronic] England
PMID23773180 (Publication Type: Case Reports, Letter)
Chemical References
  • Aminoquinolines
  • Antineoplastic Agents
  • Imiquimod
Topics
  • Aged
  • Aminoquinolines (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Chemotherapy, Adjuvant
  • Facial Dermatoses (drug therapy, pathology)
  • Humans
  • Imiquimod
  • Keratoacanthoma (drug therapy, pathology)
  • Lupus Vulgaris (complications)
  • Male
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: